LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 87.86 | 770.25 | 1321 | 12543 | 0.1053 | 0.1434 | MN20160304_L02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 87.86 | 770.25 | 2090 | 12543 | 0.1666 | 0.2814 | MN20160304_L02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 3.21 | 770.25 | 1022 | 904 | 1.1297 | 2.3838 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 3.21 | 770.25 | 817 | 904 | 0.9031 | 0.2892 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 5.44 | 770.25 | 1111 | 1012 | 1.0970 | 1.5285 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 5.44 | 770.25 | 903 | 1012 | 0.8916 | 0.4958 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 7.66 | 770.25 | 1189 | 1090 | 1.0908 | 1.3790 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 7.66 | 770.25 | 965 | 1090 | 0.8853 | 0.5683 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 10.06 | 770.25 | 1330 | 1218 | 1.0915 | 1.2830 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 10.06 | 770.25 | 1058 | 1218 | 0.8683 | 0.6156 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 12.28 | 770.25 | 1373 | 1358 | 1.0110 | 1.0268 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 12.28 | 770.25 | 1144 | 1358 | 0.8423 | 0.6217 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 14.50 | 770.25 | 1372 | 1497 | 0.9164 | 0.8259 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 14.50 | 770.25 | 1138 | 1497 | 0.7601 | 0.5024 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 16.73 | 770.25 | 1388 | 1664 | 0.8339 | 0.6985 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 16.73 | 770.25 | 1148 | 1664 | 0.6897 | 0.4319 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 18.95 | 770.25 | 1385 | 1832 | 0.7558 | 0.5988 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 18.95 | 770.25 | 1161 | 1832 | 0.6336 | 0.3884 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 21.17 | 770.25 | 1369 | 2008 | 0.6817 | 0.5158 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 21.17 | 770.25 | 1147 | 2008 | 0.5711 | 0.3338 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 23.39 | 770.25 | 1359 | 2244 | 0.6055 | 0.4448 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 23.39 | 770.25 | 1157 | 2244 | 0.5155 | 0.3017 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 25.62 | 770.25 | 1384 | 2514 | 0.5503 | 0.4096 | MN20160304_L02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 25.62 | 770.25 | 1160 | 2514 | 0.4613 | 0.2711 | MN20160304_L02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 27.84 | 770.25 | 1386 | 2833 | 0.4891 | 0.3670 | MN20160304_L02 | C13 |